Correlation Between Corvus Pharmaceuticals and Precigen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Corvus Pharmaceuticals and Precigen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Corvus Pharmaceuticals and Precigen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Corvus Pharmaceuticals and Precigen, you can compare the effects of market volatilities on Corvus Pharmaceuticals and Precigen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Corvus Pharmaceuticals with a short position of Precigen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Corvus Pharmaceuticals and Precigen.

Diversification Opportunities for Corvus Pharmaceuticals and Precigen

-0.62
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Corvus and Precigen is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding Corvus Pharmaceuticals and Precigen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Precigen and Corvus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Corvus Pharmaceuticals are associated (or correlated) with Precigen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Precigen has no effect on the direction of Corvus Pharmaceuticals i.e., Corvus Pharmaceuticals and Precigen go up and down completely randomly.

Pair Corralation between Corvus Pharmaceuticals and Precigen

Given the investment horizon of 90 days Corvus Pharmaceuticals is expected to generate 1.19 times more return on investment than Precigen. However, Corvus Pharmaceuticals is 1.19 times more volatile than Precigen. It trades about 0.1 of its potential returns per unit of risk. Precigen is currently generating about 0.0 per unit of risk. If you would invest  100.00  in Corvus Pharmaceuticals on August 31, 2024 and sell it today you would earn a total of  842.00  from holding Corvus Pharmaceuticals or generate 842.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Corvus Pharmaceuticals  vs.  Precigen

 Performance 
       Timeline  
Corvus Pharmaceuticals 

Risk-Adjusted Performance

24 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Corvus Pharmaceuticals are ranked lower than 24 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Corvus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.
Precigen 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Precigen has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's technical and fundamental indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Corvus Pharmaceuticals and Precigen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Corvus Pharmaceuticals and Precigen

The main advantage of trading using opposite Corvus Pharmaceuticals and Precigen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Corvus Pharmaceuticals position performs unexpectedly, Precigen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Precigen will offset losses from the drop in Precigen's long position.
The idea behind Corvus Pharmaceuticals and Precigen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.